|
|
|
|
Partners |
Mr. Barry joined Essex from Novartis Pharma AG where he most recently
served as the Global Head of Pharma M&A and Collaborations. In
this role, he was responsible for global acquisitions, equity
investments and corporate partnerships across all therapeutic areas.
He joined Novartis in 2002 and held positions in the Business
Development & Licensing and Mergers & Acquisitions groups. Prior
to joining Novartis, Mr. Barry was a Director for Century Capital
Associates LLC, a boutique healthcare investment bank and consulting
firm. There he focused on mergers & acquisitions, strategic
partnering and financing transactions. Previously, Mr. Barry held
positions at KPMG LLP in their healthcare corporate finance group and
assurance services group.
Mr. Barry serves as a director on the boards of
Orthovita, Inc. and
Bledsoe,
and as an observer for the board of
ZIOPHARM Oncology,
Inc. He holds a Bachelor of Arts degree from Wesleyan
University and a MBA from the Stern School of Business at NYU. |
|
|
 |
|
|
|
